No Data
No Data
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
DBS Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $900
Eli Lilly & Co: Promising Growth Driven by Innovative Pipeline and Market-Leading Weight-Loss Treatments
Why Eli Lilly and Company (LLY) Is the Best Drug Stock to Buy Now
What's Ahead for Eli Lilly and Novo as RFK Jr. Takes Over HHS
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Oh its going : Nothing.
Madhusudhan Talluri : not finding any news.... the way it dropped all thru day it looks like an algo selling - someone big probably unloading after recent spike.
Junius Falcon : It is normal to retrace to a previous jump gap to provide market liquidity.
Technically, it hit a resistance level and it retraces